Psyence Biomedical Ltd. (PBM) Ownership
PBM ownership summary
as of October 18, 2026- Institutions
- 13.2% of shares outstanding
- Insiders
- 2.97% of shares outstanding
- Shares outstanding
- 3.8M
- Float
- 1.1M shares available to trade
- Short interest
- 1.01% 27K shares short
- Days to cover
- 0.31 short interest down 44.3% vs prior month
- Institutions 13.24%
- Insiders 2.97%
- Other investors 83.79%
PBM top institutional holders
10 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Parallel Advisors, LLC | 3.97% | 151K | $638,275 | — | June 30, 2026 |
| 2 | AdvisorShares Investments, LLC | 3.20% | 122K | $515,616 | +122,184 (0.0%) | June 30, 2026 |
| 3 | Morgan Stanley - Brokerage Accounts | 0.99% | 38K | $159,533 | +37,804 (0.0%) | June 30, 2026 |
| 4 | Jane Street Group LLC | 0.80% | 30K | $128,419 | +30,431 (0.0%) | June 30, 2026 |
| 5 | XTX Topco Ltd | 0.40% | 15K | $63,697 | +15,094 (0.0%) | June 30, 2026 |
| 6 | Citadel Advisors Llc | 0.31% | 12K | $49,344 | +11,693 (0.0%) | June 30, 2026 |
| 7 | Stonehage Fleming Financial Services Holdings Ltd | <0.01% | 89 | $376 | — | June 30, 2026 |
| 8 | UBS Group AG | <0.01% | 60 | $253 | +60 (0.0%) | June 30, 2026 |
| 9 | Caitlin John LLC | <0.01% | 35 | $148 | +35 (0.0%) | June 30, 2026 |
| 10 | Bank of America Corp | 0.00% | — | — | −535 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 10, 7 holders added 217K shares and 1 cut 535.
PBM top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | AdvisorShares Psychedelics ETF | 6.78% | 259K | $1.1M | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
PBM shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PBM
Institutional investors own 13.2% of Psyence Biomedical Ltd.'s shares and insiders 2.97%. The largest holder is Parallel Advisors, LLC with 3.97% of the shares (151K), as of June 30, 2026. Among the top 10 institutions, 7 added shares and 1 reduced their stake in the latest filings. Short interest is 1.01% of the float, or 0.31 days of average trading volume. The share count fell 95.5% since 2021.
Related: PBM key metrics. See the PBM stock overview for the latest quote and news.
PBM ownership FAQ
Who owns the most Psyence Biomedical Ltd. stock?
The largest shareholders of Psyence Biomedical Ltd. are Parallel Advisors, LLC (3.97%), AdvisorShares Investments, LLC (3.20%), Morgan Stanley - Brokerage Accounts (0.99%), Jane Street Group LLC (0.80%), XTX Topco Ltd (0.40%).
What percentage of Psyence Biomedical Ltd. is owned by institutions?
Institutions hold 13.2% of Psyence Biomedical Ltd.'s shares outstanding; insiders hold 2.97%.
Which funds own Psyence Biomedical Ltd.?
The largest fund holders of Psyence Biomedical Ltd. are AdvisorShares Psychedelics ETF (6.78%).
What is Psyence Biomedical Ltd.'s short interest?
27K shares of Psyence Biomedical Ltd. were sold short, 1.01% of the float; at the average daily volume it would take 0.31 days to cover.
How many shares of Psyence Biomedical Ltd. are outstanding?
Psyence Biomedical Ltd. has 3.8M shares outstanding, of which 1.1M are in the public float.